Klinika Oczna Suplement

Abstract

3/2004 vol. 106
Experimental research

An­gio­ge­nic ac­ti­vi­ty and VEGF le­vel in se­ra of dia­be­tic pa­tients with non­-pr­ol­if­er­at­ive re­ti­no­pa­thy

  1. Z Katedry i Kliniki Okulistyki II Wydziału Lekarskiego Akademii Medycznej w Warszawie
  2. Z Zakładu Histologii i Embriologii, Centrum Biostruktury
  3. Z III Kliniki Chorób Wewnętrznych II Wydziału Lekarskiego Akademii Medycznej w Warszawie
  4. Z Kliniki Chorób Wewnętrznych Oddziału Stomatologii Akademii Medycznej w Warszawie
  5. Z Zakładu Diagnostyki Laboratoryjnej i Immunologii Instytutu Gruźlicy i Chorób Płuc w Warszawie
KLINIKA OCZNA 2004, Supl. 3: S421–S423
Online publish date: 2022/12/29
View full text
Diabetic retinopathy is one of the most common causes of blindness. The majority of studies concerning this problem were performed in patients with late stage of disease, demonstrating proliferative retinopathy, when malformations of retinal vessels became irreversible (1). Numerous angiogenic factors related to retinal angiogenesis have been described. Among them, VEGF is thought to be the major mediator of proliferative retinopathy (2,3,4). Our present study was performed on sera collected from patients with earlier stage of ocular complications, manifested as background retinopathy. We have believed that the knowledge of the earliest events leading to pathological angiogenesis may be valuable for establishing some prophylactic regimens. Sera of 22 persons with DM1, aged 33-70 years, 37 persons with DM2, aged 37-79 years, 51 healthy people, aged 22-80 years (as controls) were studied. Direct serum-induced cutaneous angiogenesis test in mice (SIA) was applied (5,6). VEGF concentration in sera was mesured by ELISA (R & D Systems) test. Angiogenic activity and VEGF concentration of DM1 patients sera were highly statistically lower than these parameters in DM2 patients and controls.
Share